戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ent responses to sorafenib treatment that is durable.
2 h makes for an instrument that can be highly durable.
3                                 To achieve a durable adaptive immune response, lymphocytes must under
4 requiring a multispecies community to form a durable adhesion phenotype.
5 ourse early in life is sufficient to lead to durable alterations to the murine intestinal microbiota,
6        Ideally, SOCs should perform well, be durable and be inexpensive, but there are often competit
7                              DC/CoAT induced durable and complete remissions of large subcutaneous tu
8                             Herein, a highly durable and efficient carbide-based bifunctional catalys
9                  Complementarily, these more durable and efficient dentitions could be selected to co
10 oduce plants with multiple R genes providing durable and environmentally safe protection against path
11 s can resist some antibiotics because of its durable and impermeable cell envelope.
12 gent and combination regimens, have produced durable and long-lasting clinical responses in a subset
13                                      Purpose Durable and long-term responses to the poly (ADP-ribose)
14 t protective HLA class I alleles may be more durable and mediated by CD8(+) T cell-independent mechan
15                   However, responses are not durable and resistance develops within months.
16 s, which may support the development of more durable and successful cancer immunotherapy approaches i
17      Electric eel-skin-inspired mechanically durable and super-stretchable nanogenerator is demonstra
18 nt due to its great potential for generating durable and synergistic antitumor response.
19 ) and commercial superglue is combined and a durable and ultrarobust antifouling zwitterionic (DURA-Z
20 moricidal effects to harness tumor-specific, durable, and systemic antitumor immunity with minimal to
21 or the development of even more powerful and durable antibiotics.
22 301S tau transgenic mice results in high and durable antibody expression, primarily in neurons.
23 h NP TLR L adjuvants in promoting robust and durable antibody responses against HIV in the next gener
24 ulated TLR ligands (NP) to induce potent and durable antibody responses that last a lifetime in mice.
25 ival of bone marrow-derived plasma cells and durable antibody responses to multiple virus and vaccine
26 /m(2) is a safe therapy with encouraging and durable anticancer activity in patients with R/R NHL.
27     Such antibiotics are expected to display durable antimicrobial activity not prone to rapidly acqu
28 ected) immune checkpoint blockade results in durable antitumor activity in many advanced malignancies
29               Purpose Pembrolizumab provides durable antitumor activity in metastatic melanoma, inclu
30 in dosages and thereby produces a strong and durable antitumor effect.
31 t antibodies can lead to tumor clearance and durable antitumor immunity.
32  MEK inhibitors in vivo to elicit potent and durable antitumor responses, including by a vaccine-like
33 system can be activated to induce long-term, durable antitumor responses.
34 ated HER2-targeted phagocytosis and produced durable antitumour immune responses against HER2-express
35                           This effective and durable antiviral response probably participates in a vi
36  surfaces that are stable under pressure and durable at elevated temperatures.
37  HIV vaccines capable of inducing potent and durable B-cell responses have been unsuccessful until no
38                        We found superior and durable B-cell responses in macaques vaccinated with an
39 d consequently a lack of strong, robust, and durable B-memory responses.
40 n cancer patients, the response is often not durable because tumor cells develop resistance to the dr
41                      Conclusion Olaparib has durable benefit for patients with ovarian cancer beyond
42 n why T-cell-based immunotherapy can provide durable benefits with relatively infrequent escape.
43 as inexpensive and effective means to create durable, biologically active biomaterials.
44 c bypass surgery resulted in substantial and durable bodyweight reduction and cardiometabolic benefit
45 velopment is an ability to elicit strong and durable broadly neutralizing antibody (bNAb) responses.
46 nd uses is construction decisions for highly durable buildings made under weak institutions.
47 e been shown to induce substantial levels of durable, but primarily T-cell-biased responses against t
48  a great need for cost effective, active and durable catalyst materials to replace the precious plati
49        Developing a low cost, highly active, durable cathode towards an oxygen reduction reaction (OR
50 se results demonstrate that obesity produces durable changes in HSC function and phenotype and that e
51 er training regimens (FTM or LTM) can induce durable changes in the parameters of locomotion.
52 Cefoxitin treatment resulted in complete and durable clearance of ETBF colonization.
53 is interim analysis show that venetoclax has durable clinical activity and favourable tolerability in
54 ion and provides additional evidence for the durable clinical activity of immune checkpoint inhibitor
55 igand 1 (PD-L1) with atezolizumab can induce durable clinical benefit (DCB) in patients with metastat
56 an melanoma, most patients do not experience durable clinical benefit.
57 een approved for treating human cancers with durable clinical benefit.
58                               Conclusion The durable clinical efficacy and safety of MR imaging-guide
59                       Low-dose IL-2 provides durable clinical improvement in active cGVHD and extende
60 utochthonous tumor debulking and resulted in durable clinical remission.
61             Antibodies targeting PD-1 elicit durable clinical responses in patients with multiple tum
62 med cell death 1 ligand 1) have demonstrated durable clinical responses in patients with non-small-ce
63 n 1/programmed death-ligand 1 have displayed durable clinical responses in various cancers.
64 Ls with CTLA-4 blockade is safe and produces durable clinical responses, likely reflecting both enhan
65 its receptor PD-1 has produced unparalleled, durable clinical responses, with highest likelihood of r
66                                   Marked and durable CMV-specific T-cell responses were also detected
67 veloped to create a new highly efficient and durable cobalt-based electrocatalyst for the oxygen evol
68  settlements allowed house mice to establish durable commensal populations that expanded with human s
69 n Patients with metastatic melanoma can have durable complete remission after discontinuation of pemb
70 mphoproliferative syndrome (ALPS) achieved a durable complete response (CR), including rapid improvem
71 objective response (20%), including 1 with a durable complete response.
72   Identification of low cost, highly active, durable completely noble metal-free electro-catalyst for
73           Treatments aimed at mitigating the durable consequences of early-life cocaine use may benef
74 testinal microbiome and highlight unexpected durable consequences of treatment for the world's most c
75 assessments of adult patients implanted with durable continuous-flow LVADs as bridge to transplant, d
76                     Eight patients (16%) had durable control of disease for > 12 months.
77 ity of utilizing RNA interference to achieve durable correction of hair structural phenotypes through
78                    The mechanisms underlying durable CR require further investigation.
79 results in frequent infections and a lack of durable cross-protection.
80                                  LAIV boosts durable, cross-reactive T-cell responses in children and
81 umors ultimately arise for which there is no durable cure.
82 sis, compared with patients who will achieve durable cure.
83 ne checkpoint inhibitor biologics to produce durable cures in mouse models of glioblastoma in which s
84 on resultant from brief DCS application into durable DCS-LTD.
85             Conclusion Everolimus may induce durable disease control in a high percentage of patients
86 creased the proportion of patients achieving durable disease control with excellent results, as measu
87 nomodulatory antibodies offer the promise of durable disease control.
88 ll enable delivery of improved diagnosis and durable disease-control strategies.
89 s to improve broad-spectrum, and potentially durable, disease resistance in crops.
90                              This effect was durable during the follow-up year.
91 ation; however, these regimens do not have a durable effect on long-term graft survival owing to a co
92 wed a statistically significant, robust, and durable effect on pain intensity, indicating that MBCT m
93 ions of 15d-PGJ2 in the cream showing a more durable effect up to 8h.
94 ll-directed immunotherapy might lead to more durable efficacy, T cell responses are themselves at lea
95 vel cobalt alloy-based coronary stent with a durable elastomeric polymer eluting the antiproliferativ
96 article form of Env (VLP) induces potent and durable Env-specific antibody responses in the serum and
97                                              Durable expression of GUCY2C, guanylin, and uroguanylin
98 oaches for more selective and therefore more durable Fe-N-C catalysts.
99 r mechanical energy harvesting by creating a durable ferroelectret energy harvester/nanogenerator (FT
100 d in later retrieval, formed memories appear durable for at least 48 h.
101 Cs from poorly controlled patients to induce durable GAD65-specific T cell hyporesponsiveness was rev
102 ch, education, environmental assessments, or durable goods integral to home environmental interventio
103 CIST (version 1.1); however, 17 (33%) showed durable (>/= 4 months) stable disease, including seven (
104 ION: Pegylated interferon alfa-2a can induce durable haematological and molecular responses in patien
105                  The weighted probability of durable HBeAg seroconversion was 91.9% and 88.0% at 12 a
106 nsplantation for chronic hepatitis B, with a durable HBsAg seroclearance rate of 92%, an undetectable
107 t of C57BL/6 mice permitted establishment of durable hematopoietic chimerism when the mice were given
108 vide phenotypic and mechanistic insight into durable hematopoietic dysregulations resulting from obes
109                                              Durable, highly efficient, and economic sound electrocat
110 ible SiCl4 cross-linking chemistry to create durable hybrid solid-electrolyte interphases (SEIs) on m
111 imod and establishment of tumor-specific and durable immune memory.
112 tionized the treatment of cancer by inducing durable immune responses and clinical remissions in pati
113 -based nanoparticles (NPs) induce robust and durable immune responses in mice and macaques.
114  Overcoming the immune response to establish durable immune tolerance in type 1 diabetes remains a su
115 ttenuated vaccines typically offer rapid and durable immunity but have reduced safety when compared t
116  reversal at 3 years, reflecting a lack of a durable immunologic effect.
117 ified effectively with therapy and generated durable immunologic memory.
118  Treatment with CN-105 was associated with a durable improvement in functional outcomes as assessed b
119                            PDP enabled these durable improvements by targeting multiple tumor compart
120 recent progress, results after treatment are durable in half of patients, and therapy can be associat
121 This hydrophilic hybrid muscle is physically durable in solution and responds to electric field stimu
122                              Engraftment was durable in the majority of chimeras and increased over t
123                                  SVR appears durable in the majority of patients at 5 years post-trea
124                 Although responses have been durable in the majority of patients, relapses do occur,
125 adventitial delivery of resveratrol produces durable inhibition of all three pro-restenotic pathologi
126  whereas virus-specific exhaustion imparts a durable inhibitory imprint on cell function.
127 ctivation in skeletal muscle induced robust, durable, insulin-independent glucose uptake and glycogen
128 hen acquiring and then effectively retaining durable knowledge that is associated to preexisting know
129 ted B-cell responses proved to be remarkably durable, lasting more than 60 weeks postimmunization.IMP
130 ment, a 30-min practice break also disrupted durable learning on a non-native phonetic classification
131        Time-course studies demonstrated that durable leukemia remission required CAR T-cell persisten
132               These studies demonstrate that durable levels of protective antitoxin immunity exist in
133 ped in the lubricating liquid to result in a durable, liquid-repellent surface.
134 of patients with metastatic GIST experiences durable, long-term overall survival with imatinib treatm
135  adverse kidney events (death, dialysis, and durable loss of renal function [chronic kidney disease])
136 nduced by a typical American diet reflects a durable loss of taxa that is replenished only when dieta
137                                              Durable LVADs included 108 Heartmate II (HM II) and 105
138 ies of neighboring endogenous microglia in a durable manner.
139 g CLTS were less likely to be constructed of durable materials than pre-existing latrines, but were e
140 ory VAs, including heart transplantation and durable mechanical circulatory support, may be required
141                               Responses were durable (median response duration 12.0 months [95% CI 3.
142                 These findings highlight how durable memories are formed.
143 the neuronal predictors for the formation of durable memories largely unknown.
144                                          For durable memory encoding, we found increased activation i
145 ic MET exon 14 mutants, which propagate more durable MET signals due to a defect in receptor degradat
146 uch as Mg, Ti, and Zr are lightweight and/or durable metals with critical structural applications in
147                        All patients achieved durable MGFA complete stable remission with no residual
148 recipient regulatory T (Treg) cells promotes durable mixed hematopoietic chimerism and allograft tole
149 he ZIKV outbreak in 2013 elicited potent and durable neutralizing antibody responses in mice and non-
150 antinib demonstrated clinically significant, durable objective response activity in patients with RAI
151  with diffuse large B-cell lymphoma achieved durable objective responses (two complete responses at 1
152 heckpoint blockade has led to remarkable and durable objective responses in a number of different tum
153                                              Durable objective responses show the potential of nivolu
154   Long-term follow-up is needed to establish durable oncologic efficacy and survival relative to comp
155 HER2 V777_G778insGSP mutation and achieved a durable partial response.
156 his suggests that the requisite practice for durable perceptual learning is integrated throughout eac
157                                          The durable performance of these strains confirms the potent
158   Moreover, the vaccine effects proved to be durable, persisting for over eight months.
159       Our discovery identifies a new type of durable plant resistance gene conferring quantitative di
160 with shorter follow-up, this therapy elicits durable plateaus of long-term OS and progression-free su
161                                              Durable platelet response rates with romiplostim by age
162                        The primary endpoint, durable platelet response, was defined as achievement of
163 lack-supported cost-effective, efficient and durable platinum single-atom electrocatalyst with carbon
164 eloped to overcome the limitation of current durable polymer drug-eluting stents eluting amorphous si
165 tent sirolimus-eluting stent compared with a durable polymer drug-eluting stents has not been investi
166 nt group and 41 (10%) of 427 patients in the durable polymer everolimus-eluting stent group met the 1
167 ymer sirolimus-eluting stent compared with a durable polymer everolimus-eluting stent in a broad pati
168 ble polymer sirolimus-eluting stent over the durable polymer everolimus-eluting stent in a complex pa
169 rolimus-eluting stent is non-inferior to the durable polymer everolimus-eluting stent was 100% (Bayes
170 sorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent with Bayesian m
171 able polymer sirolimus-eluting stent or to a durable polymer everolimus-eluting stent.
172  polymer sirolimus-eluting stents (n=884) or durable polymer everolimus-eluting stents (n=450).
173 mer stent (MiStent) or an everolimus-eluting durable polymer stent (Xience).
174 t was non-inferior to the everolimus-eluting durable polymer stent for a device-oriented composite cl
175                      Lack of availability of durable, potent drugs in child-friendly formulations in
176 re perishable, dried extracts emerge as more durable products and their quality control must include
177             Collectively, these data suggest durable protection against homologous and heterologous P
178  not succeed in raising safe, effective, and durable protection against human Zika virus infections o
179 indings suggest that PfSPZ Vaccine conferred durable protection to malaria through long-lived tissue-
180  subsets that together provide immediate and durable protection.
181  of these NP adjuvants to promote robust and durable protective immune responses against SIV in nonhu
182 cleoside-modified mRNA-LNP elicits rapid and durable protective immunity and therefore represents a n
183 ated ablation produced rapid, efficient, and durable PV isolation.
184 py)3](2+)-GO electrodes exhibit superior and durable redox properties compared to the pristine carbon
185 These data demonstrate that SPX-101 promotes durable reduction of ENaC membrane concentration, leadin
186       These findings suggest significant and durable reductions of inpatient use and cost of health c
187 f PD-1 in humans has resulted in impressive, durable regression responses in select tumor types.
188 points PD-1 and CTLA-4, induced complete and durable regressions (>1 year) of established TNBC tumors
189           A single dose of SGN-CD19B induced durable regressions at 300 mug/kg (3 mug/kg drug equival
190  panel of malignant B-cell lines and induced durable regressions in mice bearing xenografts derived f
191 n anti-PD-1 nonresponders led to a complete, durable rejection of essentially all injected tumors and
192 hat target the inflammasome may lead to more durable remission and resolution.
193                                High rates of durable remission were observed, with recovery of B cell
194                                              Durable remissions associated with improved renal surviv
195 ate of peripheral neuropathy resolution, and durable remissions in a subset of patients with relapsed
196    Currently, therapies capable of providing durable remissions in relapsed/refractory TP53- or ATM-d
197   Ibrutinib produces high response rates and durable remissions in Waldenstrom macroglobulinemia (WM)
198 ic leukemia (ALL) is critical for sustaining durable remissions; accuracy of self-reported 6MP intake
199 ance genes, have promise for providing broad durable resistance in crop species.
200 this novel allele as a strategy for breeding durable resistance in rice.
201  R genes in a crop, which might provide more durable resistance.
202 actory AChR+ MG, who were observed to have a durable response after treatment.
203                   To determine mechanisms of durable response and resistance to olaparib therapy, we
204  mg being sufficient to consistently achieve durable response in MCL.
205 age by RNase H1 in vitro and provides a more durable response in mice than stereorandom ASOs.
206 onse rate was 50%, and 44% of patients had a durable response lasting >/= 6 months.
207 tients with advanced colon cancer, but their durable response rate remains low.
208 ERPRETATION: Atezolizumab showed encouraging durable response rates, survival, and tolerability, supp
209 , many patients do not achieve a complete or durable response suggesting an opportunity to improve up
210 d HDAC2 gene expression were associated with durable response to treatment.
211 rrent liposomal drug therapy, a complete and durable response was obtained using protocols for which
212 ere also noted for prevention of recurrence, durable response, and bowel movement urgency.
213 cell therapy with axi-cel had high levels of durable response, with a safety profile that included my
214 ty characterised by a high response rate and durable response.
215  itself, which correlated significantly with durable response.
216 ty characterised by a high response rate and durable response.
217 generally well tolerated and may result in a durable response.
218  patients treated with immunotherapy exhibit durable response; the integration of nanomedicine and im
219 therapy is reasonable in patients with prior durable responses (time to next therapy >/=3 years) and
220 labrutinib treatment provided a high rate of durable responses and a favourable safety profile in pat
221           INTERPRETATION: Nivolumab provided durable responses and disease control in pre-treated pat
222 reatment were analyzed for associations with durable responses and OS.
223 lumab was well tolerated and associated with durable responses and prolonged survival in patients wit
224 uration, chemotherapy-free regimen, inducing durable responses and with a favorable long-term toxicit
225                        However, complete and durable responses are only seen in a fraction of patient
226 nclusion Nivolumab demonstrated higher, more durable responses but no difference in survival compared
227                                     Although durable responses can be achieved in some patients, many
228 lators on T cells-could provide improved and durable responses for patients with disease that is othe
229                                     However, durable responses have been elusive in ovarian cancer pa
230          In summary, sirolimus led to CR and durable responses in a majority of children with refract
231 mmune-checkpoint blockade is able to achieve durable responses in a subset of patients; however, we l
232 activation by checkpoint inhibitors leads to durable responses in a variety of cancers, but combinati
233 sion IMMU-132 was well-tolerated and induced durable responses in heavily pretreated patients with me
234 can was well tolerated and induced early and durable responses in heavily pretreated patients with me
235 n-to-treat population showed well-tolerated, durable responses in line with previous phase 2 data for
236 ecules such as CTLA-4 and PD-1 have achieved durable responses in melanoma, renal cancer, Hodgkin's d
237 tions in vitro, and resulted in complete and durable responses in neuroblastoma xenografts derived fr
238 b, allowing prolonged exposure and promising durable responses in pazopanib- and other VEGF inhibitor
239                        Ibrutinib has induced durable responses in previously treated patients with Wa
240 ose dexamethasone have acceptable safety and durable responses in RRMM patients.
241 ade or adoptive T-cell transfer, can lead to durable responses in the clinic, but response rates rema
242  in treated cancers can either contribute to durable responses or drive relapse.
243 essing relapsed or refractory lymphomas have durable responses to single-agent brentuximab vedotin an
244                        However, complete and durable responses to targeted therapy are rare in indivi
245 ion of MAPK pathway signaling, thus limiting durable responses to the current BRAF inhibitors.
246                                    Rapid and durable responses were observed in a minority of patient
247                                              Durable responses were observed in association with seve
248                                        Deep, durable responses were observed in heavily treated patie
249                                              Durable responses were observed with nivolumab; 10 (37%)
250               Single-agent ibrutinib induced durable responses with a favorable benefit-risk profile
251 able safety, notable antitumor activity, and durable responses with promising OS in patients with mRC
252  PD-L1/PD-1, only a subset of people exhibit durable responses, suggesting that a broader view of can
253  only a subset of patients exhibit clear and durable responses, suggesting that other mechanisms must
254 stemic therapies rarely provide reliable and durable responses.
255 omide/dexamethasone resulted in rapid, deep, durable responses.
256 ler for treatment of HIV-associated FLA with durable results at 12 months.
257 ociated with the highest accuracy to predict durable segments (area under the curve=0.73).
258 nd depth, is the most accurate predictor for durable segments.
259 linical setting would require disposable and durable sensors to provide better therapies and quality
260 -GO1 resulted in potent, dose-dependent, and durable silencing of the mRNA encoding glycolate oxidase
261 en thermal and electrical energy by means of durable, silent and scalable solid-state thermoelectric
262 V and EEEV E2/E1 glycoproteins also provided durable, single-dose protection from lethal VEEV and EEE
263 e newly elected parliament must pursue for a durable solution.
264 m-positive bacterium Bacillus subtilis forms durable spores for survival.
265 reagents are "on-chip," and these chips show durable storage stability without cold storage.
266                         Developing cheap yet durable substitutes of precious-metal catalysts, especia
267                                         This durable suppression was due in part to epigenetic change
268                                              Durable surveillance and programs that emphasize the jud
269 M performed by experienced surgeons provided durable symptomatic relief in 94% of patients with nonsp
270 tallographic imperfections renders them more durable than their bulk counterparts.
271 unotherapy will likely be required to impart durable therapeutic efficacy.
272 and p110alpha/beta may serve as a potent and durable therapeutic regimen for the treatment of HER2+,
273  cell death 1 ligand 1 (PD1/PD-L1) generates durable therapeutic responses in a significant subset of
274 ty profiles, are required for development of durable therapy for these currently intractable disorder
275 llergic immunity abrogated the potential for durable tolerance.
276  ultrasound (HIFU) is a safe, effective, and durable treatment option for the management of osteoid o
277                      Robust, functional, and durable Triplex-driven expansions of CMV-specific T cell
278                      High-dose SSRS provides durable tumor control when used either as definitive the
279  the same way also displayed more robust and durable tumor control.
280 ligand 1 (PD-L1) resulted in synergistic and durable tumor regression even where either agent alone w
281 ists have now produced a compound that shows durable tumor regression in a lymphoma xenograft model.
282           Cancer immunotherapy can result in durable tumor regressions in some patients.
283 ined inhibition of PI3K and mTOR resulted in durable tumor regressions in three of five PDXs, and the
284                                              Durable tumor regressions were observed in seven (70%) o
285     Furthermore, we demonstrated evidence of durable tumor-specific antitumor immunity.
286 ted powdery mildew fungus, thus regulating a durable type of defense that works in both host and nonh
287                                              Durable undetectability of HDV RNA is a valid surrogate
288 rcentage of persons in HIV care who achieved durable viral suppression (all VL results <200 copies/mL
289        Two-thirds of persons in HIV care had durable viral suppression during a 2-year period.
290                                  We examined durable viral suppression, cumulative viral load (VL) bu
291 care, antiretroviral therapy initiation, and durable viral suppression, will be important components
292 py (ART), and 90% of individuals on ART have durable viral suppression.
293                          The pooled rates of durable VR remission were 51.4%, 39.3%, and 38.2% at 12,
294                                              Durable VR seems to be feasible in a substantial proport
295                  Although most patients have durable weight loss after total gastrectomy, weights sta
296  sleeve gastrectomy, produce significant and durable weight loss in both humans and rodents.
297 ential to replicate the strong, instant, and durable wet adhesion of the marine sessile organism.
298                                          The durable whole-body responses reported, together with the
299                               Responses were durable, with median progression-free survival and overa
300 ssential component of safe, efficacious, and durable Zika virus vaccines.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top